Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse…
US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
US FTC wins ruling blocking Edwards Lifesciences’ acquisition of JenaValve
Jan 9 (Reuters) – The U.S. Federal Trade Commission won a ruling on Friday blocking Edwards Lifesciences’ (EW.N),…
US CDC says 2025-26 flu season ‘moderately severe’ as cases hit 11 million
Item 1 of 2 A sign advertises flu, pneumonia, and shingles vaccine shots at a Walgreens pharmacy in…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
Medicare enrollees to pay 50% less for some drugs in 2025, report says
AARP study looks at first 10 drugs negotiated under IRA Finds 7 of the drugs will cost under…
Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs
DEC 15 (Reuters) – A federal judicial panel said Monday it would centralize a growing number of lawsuits…
FDA approves BioCryst’s oral pellet version of swelling disorder drug for children
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
US FDA approves first at-home device for depression
Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device…
US FDA qualifies first AI tool to help speed liver disease drug development
Dec 8 (Reuters) – The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed…
AI’s rise stirs excitement, sparks job worries
AI’s impact on job growth and work transformation discussed at Reuters NEXT Concerns over AI’s role in job…
CVS to pay $37.8 million to settle claims over insulin pens
CVS said to obtain reimbursement for excess insulin pens Whistleblower to share settlement proceeds CVS says insulin pen…